Clinical Technology Act Advnc is categorized under Research and Development Laboratories in Livonia, MI and active since 2010.
Clinical Technology Act Advnc was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 8112191 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 18241 Pershing St, Livonia, Michigan MI 48152 or by phoning (313) 592-8476. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Technology Act Advnc |
| Address: | 18241 Pershing St, Livonia, Michigan 48152 |
| Phone Number: | (313) 592-8476 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 8112191 |
| Share This Business: |
Clinical Technology Act Advnc was started in 2010 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 8112191. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact for inquiries that concern Clinical Technology Act Advnc by calling the company number (313) 592-8476, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Technology Act Advnc can be found at the coordinates 42.420691,-83.317744 as well as the street address 18241 Pershing St in Livonia, Michigan 48152.
For its online presence, you may visit Clinical Technology Act Advnc’s website at and engage with its social media outlets through on Twitter and on Facebook.